HomeCompareBLDEW vs ABBV

BLDEW vs ABBV: Dividend Comparison 2026

BLDEW yields 1114.83% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLDEW wins by $48920771.58M in total portfolio value
10 years
BLDEW
BLDEW
● Live price
1114.83%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$48920771.69M
Annual income
$41,583,260,751,770.79
Full BLDEW calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — BLDEW vs ABBV

📍 BLDEW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLDEWABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLDEW + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLDEW pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLDEW
Annual income on $10K today (after 15% tax)
$94,760.31/yr
After 10yr DRIP, annual income (after tax)
$35,345,771,639,005.17/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, BLDEW beats the other by $35,345,771,617,949.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLDEW + ABBV for your $10,000?

BLDEW: 50%ABBV: 50%
100% ABBV50/50100% BLDEW
Portfolio after 10yr
$24460385.89M
Annual income
$20,791,630,388,271.28/yr
Blended yield
85.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

BLDEW
No analyst data
Altman Z
0.5
Piotroski
5/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLDEW buys
0
ABBV buys
0
No recent congressional trades found for BLDEW or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLDEWABBV
Forward yield1114.83%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$48920771.69M$102.3K
Annual income after 10y$41,583,260,751,770.79$24,771.77
Total dividends collected$48368264.72M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BLDEW vs ABBV ($10,000, DRIP)

YearBLDEW PortfolioBLDEW Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$122,183$111,482.72$11,550$430.00+$110.6KBLDEW
2$1,403,751$1,273,015.14$13,472$627.96+$1.39MBLDEW
3$15,170,800$13,668,786.88$15,906$926.08+$15.15MBLDEW
4$154,291,752$138,058,995.51$19,071$1,382.55+$154.27MBLDEW
5$1,477,337,866$1,312,245,691.79$23,302$2,095.81+$1477.31MBLDEW
6$13,323,465,908$11,742,714,391.15$29,150$3,237.93+$13323.44MBLDEW
7$113,230,332,623$98,974,224,101.73$37,536$5,121.41+$113230.30MBLDEW
8$907,267,497,317$786,111,041,410.35$50,079$8,338.38+$907267.45MBLDEW
9$6,857,486,854,397$5,886,710,632,267.96$69,753$14,065.80+$6857486.78MBLDEW
10$48,920,771,685,976$41,583,260,751,770.79$102,337$24,771.77+$48920771.58MBLDEW

BLDEW vs ABBV: Complete Analysis 2026

BLDEWStock

Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.

Full BLDEW Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this BLDEW vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLDEW vs SCHDBLDEW vs JEPIBLDEW vs OBLDEW vs KOBLDEW vs MAINBLDEW vs JNJBLDEW vs MRKBLDEW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.